- Abstract Title: Reversal of betrixaban-induced anticoagulation in healthy volunteers by andexanet alfa
- Abstract Title: Andexanet alfa reverses anticoagulation effects of enoxaparin and associated bleeding in a rabbit acute hemorrhage model
The South San Francisco, Calif.-based firm said Sept. 12 it had priced its underwritten public offering of 6.35 million shares at $55 apiece.
Jim Cramer is bullish on Norwegian Cruise Line, iRobot, Bank of America, Portola Pharmaceuticals and more.
Why is this market so lacking in follow-through? Jim Cramer says the guy in the White House is only part of the problem.
Without at least one approved drug, I am tempted to say you should just take a pass.